nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. (Record no. 21781387)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01566 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516092512.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201301s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2159-8290 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/2159-8290.CD-11-0242 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Frese, Kristopher K |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20130115 |
245 00 - TITLE STATEMENT | |
Title | nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cancer discovery |
Date of publication, distribution, etc. | Mar 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 260-269 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Albumins |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Pancreatic Ductal |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytidine Deaminase |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Models, Animal |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Synergism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Paclitaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancreatic Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Neesse, Albrecht |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cook, Natalie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bapiro, Tashinga E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lolkema, Martijn P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jodrell, Duncan I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tuveson, David A |
773 0# - HOST ITEM ENTRY | |
Title | Cancer discovery |
Related parts | vol. 2 |
-- | no. 3 |
-- | p. 260-269 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/2159-8290.CD-11-0242">https://doi.org/10.1158/2159-8290.CD-11-0242</a> |
Public note | Available from publisher's website |
No items available.